SYNGAP1 Encephalopathy
1 clinical trials · Condition
◉ Watch SYNGAP1 Encephalopathy
| Record | Firm | Date |
|---|---|---|
| Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes (NCT05232630) | Hospital Ruber Internacional | 2022-10-20 |
Track SYNGAP1 Encephalopathy automatically
Every clearance here is in the API, with alerts when new ones post.